178 related articles for article (PubMed ID: 11219327)
1. Implications of hypnotic flexibility on patterns of clinical use.
Lader MH
Int J Clin Pract Suppl; 2001 Jan; (116):14-9. PubMed ID: 11219327
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of zaleplon at peak plasma levels.
Mangano RM
Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
[TBL] [Abstract][Full Text] [Related]
3. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
4. Safety of zaleplon in the treatment of insomnia.
Israel AG; Kramer JA
Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
[TBL] [Abstract][Full Text] [Related]
5. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
Rosenberg RP
Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
[TBL] [Abstract][Full Text] [Related]
6. Treatment of insomnia with zaleplon, a novel sleep medication.
Doghramji PP
Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
[TBL] [Abstract][Full Text] [Related]
7. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Weitzel KW; Wickman JM; Augustin SG; Strom JG
Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
[TBL] [Abstract][Full Text] [Related]
8. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
9. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
Hesse LM; von Moltke LL; Greenblatt DJ
CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
[TBL] [Abstract][Full Text] [Related]
10. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement.
Montplaisir J; Hawa R; Moller H; Morin C; Fortin M; Matte J; Reinish L; Shapiro CM
Hum Psychopharmacol; 2003 Jan; 18(1):29-38. PubMed ID: 12532313
[No Abstract] [Full Text] [Related]
11. Benefit-risk assessment of zaleplon in the treatment of insomnia.
Barbera J; Shapiro C
Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
[TBL] [Abstract][Full Text] [Related]
13. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
[TBL] [Abstract][Full Text] [Related]
14. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
Fry J; Scharf M; Mangano R; Fujimori M
Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
[TBL] [Abstract][Full Text] [Related]
15. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
Huang YS; Hsu SC; Liu SI; Chen CK
Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of sedative hypnotics in older patients with insomnia.
Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
[TBL] [Abstract][Full Text] [Related]
18. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia.
Wagner J; Wagner ML; Hening WA
Ann Pharmacother; 1998 Jun; 32(6):680-91. PubMed ID: 9640488
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypnotic drugs on body balance and standing steadiness.
Mets MA; Volkerts ER; Olivier B; Verster JC
Sleep Med Rev; 2010 Aug; 14(4):259-67. PubMed ID: 20171127
[TBL] [Abstract][Full Text] [Related]
20. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.
Allain H; Bentué-Ferrer D; Polard E; Akwa Y; Patat A
Drugs Aging; 2005; 22(9):749-65. PubMed ID: 16156679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
